Experience to Support Your CNS Trials
Biopharmaceutical companies developing novel CNS products face some unique obstacles for their pivotal clinical trials, including selecting the right trial endpoints and recruiting qualified investigators and treatment-naïve patients. PAREXEL has the knowledge, experience, and resources to help you overcome these obstacles so you can conduct your trials as quickly, safely, and cost-efficiently as possible – anywhere in the world. Our team of CNS experts works in partnership with you to deliver the exact combination of services you need to shorten the Phase IIb/III development time and bring your therapy to the patients who need it.
In the past five years, PAREXEL has actively participated in more than 540 CNS studies involving more than 114,000 patients. These studies covered a wide array of disorders in psychiatry, neurology, and anesthesiology, including:
- Alzheimer’s disease
- Schizophrenia
- Multiple sclerosis
- Epilepsy
- Stroke
- Pain management
- Sleep disorders
- Migraine
- Attention deficit/hyperactivity disorder
- Neuropathic pain
- Neuro-oncology
- Parkinson’s disease
We have more than 100 project managers and 500 CRAs with specific CNS trial experience, plus a database of thousands of qualified CNS investigators in 60 countries across the globe. Our worldwide resources allow PAREXEL to more efficiently recruit treatment-naïve patients, initiate studies more quickly, and maintain consistent quality and best practices at every site.